JOSE MIGUEL
MONTEJO BARANDA
Investigador/a en el periodo 1993-2019
Hospital Universitario 12 de Octubre
Madrid, EspañaPublicaciones en colaboración con investigadoras/es de Hospital Universitario 12 de Octubre (86)
2023
-
Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort
International Journal of Infectious Diseases, Vol. 137, pp. 134-143
2022
-
Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria
Open Forum Infectious Diseases, Vol. 9, Núm. 9
2021
-
Invasive aspergillosis in solid organ transplantation: Diagnostic challenges and differences in outcome in a Spanish national cohort (Diaspersot study)
Mycoses, Vol. 64, Núm. 11, pp. 1334-1345
-
Propensity score and desirability of outcome ranking analysis of ertapenem for treatment of nonsevere bacteremic urinary tract infections due to extended-spectrum-beta-lactamase-producing enterobacterales in kidney transplant recipients
Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 11
2020
-
A New Clinical and Immunovirological Score for Predicting the Risk of Late Severe Infection in Solid Organ Transplant Recipients: The CLIV Score
The Journal of infectious diseases, Vol. 222, Núm. 3, pp. 479-487
-
An evidence-based bundle improves the quality of care and outcomes of patients with candidaemia
Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 3, pp. 730-737
-
Author Correction: Biofilm formation by multidrug resistant Enterobacteriaceae strains isolated from solid organ transplant recipients (Scientific Reports, (2019), 9, 1, (8928), 10.1038/s41598-019-45060-y)
Scientific Reports
-
Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa
Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 4
-
Executive summary of the Consensus Statement of the Transplant Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the National Transplant Organization (ONT) on the Selection Criteria of Donors of Solid Organs in relation to Infectious Diseases
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 8, pp. 379-389
-
Factors associated with the development of septic shock in patients with candidemia: A post hoc analysis from two prospective cohorts
Critical Care, Vol. 24, Núm. 1
-
Oral fosfomycin for the treatment of lower urinary tract infections among kidney transplant recipients—Results of a Spanish multicenter cohort
American Journal of Transplantation, Vol. 20, Núm. 2, pp. 451-462
-
Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients
Cell Reports Medicine, Vol. 1, Núm. 8
-
Predictors of mortality in solid organ transplant recipients with bloodstream infections due to carbapenemase-producing Enterobacterales: The impact of cytomegalovirus disease and lymphopenia
American Journal of Transplantation, Vol. 20, Núm. 6, pp. 1629-1641
-
Selection criteria of solid organ donors in relation to infectious diseases: A Spanish consensus
Transplantation Reviews, Vol. 34, Núm. 2
2019
-
Biofilm formation by multidrug resistant Enterobacteriaceae strains isolated from solid organ transplant recipients
Scientific Reports, Vol. 9, Núm. 1
-
Candidemia in solid organ transplant recipients in Spain: Epidemiological trends and determinants of outcome
Transplant Infectious Disease, Vol. 21, Núm. 6
-
Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain
Open Forum Infectious Diseases, Vol. 6, Núm. 2
-
Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): Study protocol of a retrospective multicentre international study
BMJ Open, Vol. 9, Núm. 5
-
Improvement in detecting cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance using next generation sequencing
PLoS ONE, Vol. 14, Núm. 7
-
Recommendations from a panel of experts on the usefulness of fidaxomicin for the treatment of infections caused by Clostridium difficile
Revista Espanola de Quimioterapia, Vol. 32, Núm. 1, pp. 50-59